Amalgamated Bank’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $9.81M | Buy |
108,443
+214
| +0.2% | +$17.9K | 0.07% | 234 |
|
|
2026
Q1 | $8.67M | Sell |
108,229
-2,778
| -3% | -$229K | 0.07% | 237 |
|
|
2025
Q4 | $9.46M | Sell |
111,007
-460
| -0.4% | -$37.8K | 0.07% | 215 |
|
|
2025
Q3 | $8.67M | Sell |
111,467
-1,857
| -2% | -$145K | 0.06% | 239 |
|
|
2025
Q2 | $8.86M | Sell |
113,324
-5,581
| -5% | -$416K | 0.07% | 219 |
|
|
2025
Q1 | $8.62M | Buy |
118,905
+399
| +0.3% | +$28.6K | 0.07% | 214 |
|
|
2024
Q4 | $8.77M | Sell |
118,506
-1,248
| -1% | -$87.3K | 0.07% | 212 |
|
|
2024
Q3 | $7.9M | Sell |
119,754
-3,367
| -3% | -$245K | 0.07% | 247 |
|
|
2024
Q2 | $11.4M | Sell |
123,121
-7,600
| -6% | -$673K | 0.1% | 159 |
|
|
2024
Q1 | $12.5M | Sell |
130,721
-20,649
| -14% | -$1.73M | 0.11% | 155 |
|
|
2023
Q4 | $11.5M | Sell |
151,370
-10,327
| -6% | -$719K | 0.09% | 183 |
|
|
2023
Q3 | $11.2M | Sell |
161,697
-13,480
| -8% | -$1.08M | 0.1% | 175 |
|
|
2023
Q2 | $16.5M | Buy |
175,177
+7,604
| +5% | +$661K | 0.13% | 129 |
|
|
2023
Q1 | $13.9M | Sell |
167,573
-809
| -0.5% | -$63.6K | 0.12% | 141 |
|
|
2022
Q4 | $12.6M | Sell |
168,382
-2,651
| -2% | -$204K | 0.11% | 153 |
|
|
2022
Q3 | $14.1M | Buy |
171,033
+5,805
| +4% | +$559K | 0.14% | 124 |
|
|
2022
Q2 | $15.7M | Sell |
165,228
-9,895
| -6% | -$1.02M | 0.15% | 119 |
|
|
2022
Q1 | $20.6M | Buy |
175,123
+7,137
| +4% | +$801K | 0.16% | 100 |
|
|
2021
Q4 | $21.8M | Buy |
167,986
+28,573
| +20% | +$3.33M | 0.16% | 105 |
|
|
2021
Q3 | $15.8M | Sell |
139,413
-6,348
| -4% | -$725K | 0.13% | 123 |
|
|
2021
Q2 | $15.1M | Buy |
145,761
+107,749
| +283% | +$10.2M | 0.12% | 136 |
|
|
2021
Q1 | $3.18M | Sell |
38,012
-1,798
| -5% | -$152K | 0.12% | 134 |
|
|
2020
Q4 | $3.63M | Sell |
39,810
-190
| -0.5% | -$15.8K | 0.14% | 122 |
|
|
2020
Q3 | $3.19M | Sell |
40,000
-1,200
| -3% | -$93.6K | 0.14% | 119 |
|
|
2020
Q2 | $2.85M | Sell |
41,200
-63,383
| -61% | -$4.5M | 0.13% | 128 |
|
|
2020
Q1 | $6.58M | Sell |
104,583
-3,432
| -3% | -$247K | 0.16% | 119 |
|
|
2019
Q4 | $8.4M | Buy |
108,015
+4,380
| +4% | +$342K | 0.15% | 124 |
|
|
2019
Q3 | $7.6M | Buy |
103,635
+21,000
| +25% | +$1.48M | 0.16% | 118 |
|
|
2019
Q2 | $5.09M | Sell |
82,635
-11,964
| -13% | -$723K | 0.12% | 164 |
|
|
2019
Q1 | $6.03M | Buy |
94,599
+1,977
| +2% | +$113K | 0.15% | 132 |
|
|
2018
Q4 | $4.73M | Sell |
92,622
-2,667
| -3% | -$135K | 0.13% | 141 |
|
|
2018
Q3 | $5.53M | Sell |
95,289
-3,036
| -3% | -$148K | 0.14% | 146 |
|
|
2018
Q2 | $4.77M | Buy |
98,325
+6,417
| +7% | +$300K | 0.12% | 164 |
|
|
2018
Q1 | $4.27M | Buy |
91,908
+8,976
| +11% | +$390K | 0.11% | 175 |
|
|
2017
Q4 | $3.12M | Buy |
82,932
+7,260
| +10% | +$266K | 0.08% | 222 |
|
|
2017
Q3 | $2.76M | Buy |
75,672
+1,704
| +2% | +$65K | 0.09% | 220 |
|
|
2017
Q2 | $2.92M | Buy |
73,968
+25,890
| +54% | +$945K | 0.1% | 202 |
|
|
2017
Q1 | $1.51M | Sell |
48,078
-20,616
| -30% | -$645K | 0.08% | 261 |
|
|
2016
Q4 | $2.15M | Buy |
68,694
+11,994
| +21% | +$389K | 0.1% | 189 |
|
|
2016
Q3 | $2.28M | Buy |
56,700
+72
| +0.1% | +$2.71K | 0.13% | 140 |
|
|
2016
Q2 | $2.15M | Buy |
56,628
+30,996
| +121% | +$1.06M | 0.12% | 149 |
|
|
2016
Q1 | $754K | Buy |
25,632
+6,093
| +31% | +$168K | 0.07% | 325 |
|
|
2015
Q4 | $514K | Sell |
19,539
-4,953
| -20% | -$129K | 0.06% | 425 |
|
|
2015
Q3 | $580K | Buy |
24,492
+894
| +4% | +$21.6K | 0.06% | 418 |
|
|
2015
Q2 | $560K | Buy |
23,598
+1,392
| +6% | +$31.4K | 0.06% | 482 |
|
|
2015
Q1 | $527K | Buy |
22,206
+5,190
| +31% | +$116K | 0.06% | 389 |
|
|
2014
Q4 | $361K | Sell |
17,016
-2,478
| -13% | -$49.8K | 0.06% | 482 |
|
|
2014
Q3 | $332K | Buy |
19,494
+1,224
| +7% | +$19.3K | 0.05% | 538 |
|
|
2014
Q2 | $261K | Buy |
18,270
+1,818
| +11% | +$24.6K | 0.04% | 675 |
|
|
2014
Q1 | $203K | Buy |
+16,452
| New | +$190K | 0.04% | 760 |
|
Other funds holding EW
WT
Amalgamated Bank's EW Position: Q2 2026 in Review
Amalgamated Bank increased its Edwards Lifesciences (EW) stake by 0.2% in Q2 2026, buying an estimated $17.9K and bringing the position to 108,443 shares worth $9.81M. The position accounts for 0.07% of the portfolio, ranked #234.
Amalgamated Bank first reported a position in EW in Q1 2014 and has held it in 50 quarters since. The position peaked at $21.8M in Q4 2021. 774 funds tracked by Wall St. Rank hold EW as of Q2 2026.
- Amalgamated Bank held 108,443 shares of Edwards Lifesciences worth $9.81M as of Q2 2026.
- Amalgamated Bank bought 214 Edwards Lifesciences shares in Q2 2026, an estimated $17.9K.
- Edwards Lifesciences made up 0.07% of Amalgamated Bank's portfolio in Q2 2026, its #234 holding.
- Amalgamated Bank first reported a position in Edwards Lifesciences in Q1 2014 and has held it in 50 quarters since.
- Amalgamated Bank's Edwards Lifesciences position peaked at $21.8M in Q4 2021.
- 774 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.
Based on Amalgamated Bank's 13F filing for Q2 2026, filed 23 Jul 2026.